ImpriMed, Inc.

ImpriMed, Inc.

Biotechnology Research Mountain View, California, United States 42 employees
Employees
42
Contacts
3
Emails
3
Phones
1

ImpriMed, Inc. Overview

Headquarters
Mountain View, California, United States
Industry
Biotechnology Research
Employees
42
Founded
2017
Funding
23.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ImpriMed, Inc.

ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.

ImpriMed, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

ImpriMed, Inc. Org Chart

Sample employees and titles
Name Title Contact
James Park
Email
Mary Ocnean VP Commercial Operations
View
Sean Mcdonald Founder, President & CEO Ocugenix
Email Phone
Mario Castellon, Cpa, Cgma, Mst Financial and Tax Advisor
Email

Employees by Management Level

Individual contributor 10 profiles
Manager 3 profiles
Executive 2 profiles
VP / Head 1 profile
Senior / Lead 1 profile
Intern / trainee 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 0
IT 2 2 0
Sales 2 2 0
Marketing 1 1 0
Executive 1 1 0

ImpriMed, Inc. Tech Stack

Data / AI 3 profiles
Engineering 2 profiles

Compare Similar Companies to ImpriMed, Inc.